Cirino Botta
0000-0002-1522-4504
"Annunziata" Hospital
64 papers found
Refreshing results…
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma
miR-22 suppresses DNA ligase III addiction in multiple myeloma
The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine
Mouse models of multiple myeloma: technologic platforms and perspectives
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
Anti-cancer activity of dose-fractioned mPE +/− bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)
Immunomodulatory activity of microRNAs: potential implications for multiple myeloma treatment
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
Immunotherapy of colorectal cancer: new perspectives after a long path
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse
Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation
OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response.
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients
Missing publications? Search for publications with a matching author name.